[
    {
        "id_label": "Gilead Sciences",
        "ticker": "GILD",
        "country": [
            "United States"
        ],
        "industry": [
            "pharmaceutical industry"
        ],
        "aliases": [
            "Gilead"
        ],
        "products": [
            "Atripla",
            "Descovy",
            "Emtriva",
            "Epclusa",
            "Eviplera",
            "Genvoya",
            "Harvoni",
            "Odefsey",
            "Ranexa",
            "Stribild",
            "Truvada",
            "Tybost",
            "Viread",
            "Zydelig",
            "axicabtagene ciloleucel",
            "AmBisome",
            "Complera",
            "Letairis",
            "Vemlidy",
            "Vosevi",
            "Bictegravir/emtricitabine/tenofovir alafenamide"
        ],
        "subsidiaries": [
            "Gilead Sciences (Australia)",
            "Gilead Sciences Ltd",
            "Kite Pharma"
        ],
        "owned_entities": [],
        "ceos": [
            "Daniel O'Day (Start: 2019-03-01T00:00:00Z)"
        ],
        "board_members": []
    }
]